Metraipolis › archive › dc_72437e2508fa

Fondaparinux versus argatroban for the management of suspected or confirmed heparin-induced thrombocytopenia: a propensity score-matched cohort study — Europe PMC PMID:42180757

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42180757
DOI
10.3389/fmed.2026.1794887
License (as archived)
solo-consultazione
Archived
2026-11-02T15:24:33.833Z
SHA-256 of the archived text
b4655ead7e20b49f5244719ff7e02586aca5d181e9baec5ef4457460836d8d1e
Stable URL of this page
https://metraipolis.com/documento/dc_72437e2508fa

How to cite

Fondaparinux versus argatroban for the management of suspected or confirmed heparin-induced thrombocytopenia: a propensity score-matched cohort study — Europe PMC PMID:42180757 — Europe PMC (en), https://europepmc.org/article/MED/42180757 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72437e2508fa (Metraipolis archive dc_72437e2508fa, sha256 b4655ead7e20b49f5244719ff7e02586aca5d181e9baec5ef4457460836d8d1e)
BibTeX
@misc{dc72437e2508fa,
  title = {Fondaparinux versus argatroban for the management of suspected or confirmed heparin-induced thrombocytopenia: a propensity score-matched cohort study — Europe PMC PMID:42180757},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180757},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72437e2508fa; sha256 b4655ead7e20b49f5244719ff7e02586aca5d181e9baec5ef4457460836d8d1e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180757. Agents can read the archived copy with the MCP tool read_document.